Midol and Sinusitis - a phase IV clinical study of FDA data

Summary:

Sinusitis is reported as a side effect among people who take Midol (ibuprofen), especially for people who are female, 10-19 old, also take Cymbalta, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Sinusitis when taking Midol. It is created by eHealthMe based on reports of 2,307 people who have side effects when taking Midol from the FDA, and is updated regularly.

What is Midol?

Midol has active ingredients of ibuprofen. It is often used in painful menstrual periods. eHealthMe is studying from 2,635 Midol users. Check the latest studies of Midol.

What is Sinusitis?

Sinusitis (inflammation of sinus) is found to be associated with 2,396 drugs and 2,712 conditions by eHealthMe. Check the latest studies of Sinusitis.

On Apr, 06, 2026

2,307 people reported to have side effects when taking Midol.
Among them, 16 people (0.69%) have Sinusitis.

Among these 16 people:

What is the gender of people who have Sinusitis when taking Midol? *

female: 100 %
male: 0.0 %

What is the age of people who have Sinusitis when taking Midol? *

What are other drugs people take besides Midol? *

What are other side effects people have besides Sinusitis? *

Headache (pain in head): 6 people, 37.50%
Fatigue (feeling of tiredness): 4 people, 25.00%
Infusion Site Pruritus (severe itching at infusion site): 4 people, 25.00%
Drowsiness: 4 people, 25.00%
Infusion Site Bruising: 4 people, 25.00%
Migraine (headache): 3 people, 18.75%
Diarrhea: 3 people, 18.75%
Drug Ineffective: 3 people, 18.75%
Infusion Related Reaction: 3 people, 18.75%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 12.50%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 31.25%
Immunodeficiency Common Variable: 5 people, 31.25%
Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 2 people, 12.50%
Upper Respiratory Tract Infection: 1 person, 6.25%
Sleep Disorder: 1 person, 6.25%
Pain: 1 person, 6.25%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
Muscle Spasms (muscle contraction): 1 person, 6.25%
Mood Swings (an extreme or rapid change in mood): 1 person, 6.25%
Insomnia (sleeplessness): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Midol and have Sinusitis?

- Check whether Sinusitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midol:

Midol (2,635 reports)

Sinusitis treatments and more:

Sinusitis (153,483 reports)

Browse all side effects of Midol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis:

Sinusitis (2,396 drugs)

Browse all the conditions that are associated with Sinusitis:

Sinusitis (2,712 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Midol) and Midol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.